| 1 |
35165231 | A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. | 2022 Feb 14 |
1 |
| 2 |
35380747 | The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia. | 2022 Jul |
1 |
| 3 |
34204223 | Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report. | 2021 Jun 17 |
2 |
| 4 |
34440433 | Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression. | 2021 Aug 18 |
1 |
| 5 |
34683865 | Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. | 2021 Sep 28 |
2 |
| 6 |
32276526 | Cytochrome P450 (CYP450) Interactions Involving Atypical Antipsychotics are Common in Community-Dwelling Older Adults Treated for Behavioral and Psychological Symptoms of Dementia. | 2020 Apr 8 |
1 |
| 7 |
32446424 | High Doses of Drugs Extensively Metabolized by CYP3A4 Were Needed to Reach Therapeutic Concentrations in Two Patients Taking Inducers. | 2020 Apr - Jun |
1 |
| 8 |
32910451 | [Carbamazepine and quetiapine: a neglected, but highly relevant interaction]. | 2020 |
1 |
| 9 |
33199804 | New insights into quetiapine metabolism using molecular networking. | 2020 Nov 16 |
2 |
| 10 |
29702137 | Reduced clearance of venlafaxine in a combined treatment with quetiapine. | 2018 Jul 13 |
1 |
| 11 |
28340451 | The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide. | 2017 Apr |
1 |
| 12 |
28585378 | 4β-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients. | 2017 Nov |
2 |
| 13 |
29369597 | How long does the pharmacokinetic interaction between carbamazepine and quetiapine last after carbamazepine withdrawal? | 2017 Dec |
1 |
| 14 |
25868121 | The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients. | 2015 Jun |
2 |
| 15 |
24092799 | Priapism induced by boceprevir-CYP3A4 inhibition and α-adrenergic blockade: case report. | 2014 Jan |
1 |
| 16 |
24240480 | Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers. | 2014 Jan |
1 |
| 17 |
24525658 | The influence of the CYP3A4*22 polymorphism on serum concentration of quetiapine in psychiatric patients. | 2014 Apr |
5 |
| 18 |
24797229 | Development of physiologically based pharmacokinetic model to evaluate the relative systemic exposure to quetiapine after administration of IR and XR formulations to adults, children and adolescents. | 2014 Sep |
3 |
| 19 |
23230007 | Use of high doses of quetiapine in bipolar disorder episodes are not linked to high activity of cytochrome P4503A4 and/or cytochrome P4502D6. | 2013 Sep |
3 |
| 20 |
21903893 | Investigation of a possible interaction between quetiapine and armodafinil in patients with schizophrenia: an open-label, multiple-dose study. | 2012 Sep |
1 |
| 21 |
21383647 | Pharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine in psychiatric patients. | 2011 Apr |
2 |
| 22 |
22066308 | Quetiapine. A me-too neuroleptic; no panacea. | 2011 Nov |
1 |
| 23 |
19022943 | Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome B5. | 2009 Feb |
7 |
| 24 |
18537577 | Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. | 2008 Jun |
1 |
| 25 |
17214606 | Metabolic drug interactions with newer antipsychotics: a comparative review. | 2007 Jan |
1 |
| 26 |
16390352 | Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. | 2006 Jan |
3 |
| 27 |
16841513 | In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions. | 2006 |
2 |
| 28 |
15834460 | Metabolic mechanism of quetiapine in vivo with clinical therapeutic dose. | 2005 Mar |
2 |
| 29 |
15883149 | The dosing of atypical antipsychotics. | 2005 May-Jun |
2 |
| 30 |
15516294 | A liquid chromatographic-electrospray-tandem mass spectrometric method for quantitation of quetiapine in human plasma and liver microsomes: application to study in vitro metabolism. | 2004 Sep |
1 |
| 31 |
15570533 | [Risk of QTc prolongation due to combination of ziprasidone and quetiapine]. | 2004 Nov |
1 |
| 32 |
12670127 | Interactions between the cytochrome P450 system and the second-generation antipsychotics. | 2003 Mar |
1 |
| 33 |
12186270 | New antipsychotic agents for schizophrenia: pharmacokinetics and metabolism update. | 2002 Jul |
1 |
| 34 |
10843459 | Biotransformation of post-clozapine antipsychotics: pharmacological implications. | 2000 May |
1 |
| 35 |
10917381 | Hyperventilation associated with quetiapine. | 2000 Mar |
1 |
| 36 |
11051217 | Quetiapine: a review of its safety in the management of schizophrenia. | 2000 Oct |
2 |
| 37 |
10422890 | Drug metabolism and atypical antipsychotics. | 1999 Jun |
1 |